Angiodynamics (ANGO) Research & Development (2016 - 2025)
Historic Research & Development for Angiodynamics (ANGO) over the last 17 years, with Q4 2025 value amounting to $7.8 million.
- Angiodynamics' Research & Development rose 2073.36% to $7.8 million in Q4 2025 from the same period last year, while for Nov 2025 it was $27.7 million, marking a year-over-year increase of 20.27%. This contributed to the annual value of $26.2 million for FY2025, which is 1678.73% down from last year.
- Latest data reveals that Angiodynamics reported Research & Development of $7.8 million as of Q4 2025, which was up 2073.36% from $6.4 million recorded in Q3 2025.
- In the past 5 years, Angiodynamics' Research & Development registered a high of $9.1 million during Q2 2021, and its lowest value of $6.3 million during Q3 2024.
- For the 5-year period, Angiodynamics' Research & Development averaged around $7.5 million, with its median value being $7.6 million (2021).
- Its Research & Development has fluctuated over the past 5 years, first soared by 2661.6% in 2023, then crashed by 2568.72% in 2024.
- Angiodynamics' Research & Development (Quarter) stood at $8.2 million in 2021, then dropped by 16.6% to $6.8 million in 2022, then rose by 26.62% to $8.7 million in 2023, then fell by 25.69% to $6.4 million in 2024, then grew by 20.73% to $7.8 million in 2025.
- Its last three reported values are $7.8 million in Q4 2025, $6.4 million for Q3 2025, and $6.6 million during Q2 2025.